Answer
Sure, here's a concise explanation of the verdict: Shkreli was found guilty of one count of conspiracy to commit securities fraud, for defrauding investors in his hedge fund, MSMB Capital, and his pharmaceutical company, Retrophin. The case specifically revolved around a scheme to mislead investors about the value and performance of these entities.